Literature DB >> 1420853

A theory of site distribution of melanomas: Queensland, Australia.

A Green1.   

Abstract

Although sun exposure is believed to be associated causally with cutaneous melanoma, the high incidence on less sun-exposed areas such as the back, as well as on chronically exposed sites such as the face, suggests that the association with sunlight is less straightforward than for other skin cancers. To explain this enigmatic site distribution, a theory of site-dependent susceptibility of melanocytes to malignant transformation is proposed. As possible evidence, all melanomas diagnosed in the state of Queensland, Australia, over a one-year period were surveyed for histologic evidence of benign melanocytic nevus cells adjacent to the melanoma, and analyzed according to anatomic distribution. Results showed a regional variation in the proportion of melanomas with adjacent nevi not explicable by regional variation in nevus density, which suggests that there is a varying susceptibility of nevi to malignant change. Given that nevus cells are equivalent to melanocytes, this finding would support the hypothesis that melanocytes at-large have a differential response to the mitogenic stimulus of sunlight according to anatomic site.

Entities:  

Mesh:

Year:  1992        PMID: 1420853     DOI: 10.1007/bf00052747

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  21 in total

1.  Incidence of melanocytic nevi in young adults.

Authors:  O C STEGMAIER; S W BECKER
Journal:  J Invest Dermatol       Date:  1960-02       Impact factor: 8.551

2.  What are nevus cells?

Authors:  M Magana-Garcia; A B Ackerman
Journal:  Am J Dermatopathol       Date:  1990-02       Impact factor: 1.533

3.  Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors.

Authors:  P R Gordon; C P Mansur; B A Gilchrest
Journal:  J Invest Dermatol       Date:  1989-04       Impact factor: 8.551

4.  Incidence and reporting of cutaneous melanoma in Queensland.

Authors:  A Green
Journal:  Australas J Dermatol       Date:  1982-12       Impact factor: 2.875

Review 5.  Apparent absence of a benign precursor lesion: implications for the pathogenesis of malignant melanoma.

Authors:  P M Ross
Journal:  J Am Acad Dermatol       Date:  1989-09       Impact factor: 11.527

6.  The anatomical distribution of skin cancers.

Authors:  D K Pearl; E L Scott
Journal:  Int J Epidemiol       Date:  1986-12       Impact factor: 7.196

7.  A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.

Authors:  W H Clark; D E Elder; D Guerry; M N Epstein; M H Greene; M Van Horn
Journal:  Hum Pathol       Date:  1984-12       Impact factor: 3.466

8.  Cutaneous melanoma in relation to intermittent and constant sun exposure--the Western Canada Melanoma Study.

Authors:  J M Elwood; R P Gallagher; G B Hill; J C Pearson
Journal:  Int J Cancer       Date:  1985-04-15       Impact factor: 7.396

9.  Incidence of cutaneous melanoma in the United States by histology with special reference to the face.

Authors:  G R Newell; J G Sider; L Bergfelt; M L Kripke
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

10.  Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun?

Authors:  B K Armstrong
Journal:  J Dermatol Surg Oncol       Date:  1988-08
View more
  19 in total

1.  Pigmentary traits, nevi and skin phototypes in a youth population of Central Italy.

Authors:  E Ballone; M Passamonti; G Lappa; G Di Blasio; P Fazii
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

2.  Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.

Authors:  Erin X Wei; Abrar A Qureshi; Jiali Han; Tricia Y Li; Eunyoung Cho; Jennifer Y Lin; Wen-Qing Li
Journal:  J Am Acad Dermatol       Date:  2016-07-16       Impact factor: 11.527

3.  Risk factors for malignant melanoma in white and non-white/non-African American populations: the multiethnic cohort.

Authors:  Sungshim Lani Park; Loïc Le Marchand; Lynne R Wilkens; Laurence N Kolonel; Brian E Henderson; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-13

Review 4.  The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.

Authors:  David C Whiteman; William J Pavan; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2011-08-16       Impact factor: 4.693

5.  Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.

Authors:  Reza Ghiasvand; Trude E Robsahm; Adele C Green; Corina S Rueegg; Elisabete Weiderpass; Eiliv Lund; Marit B Veierød
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

Review 6.  A new understanding in the epidemiology of melanoma.

Authors:  Esther Erdei; Salina M Torres
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

7.  Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.

Authors:  Y T Chen; T Zheng; T R Holford; M Berwick; R Dubrow
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

8.  Cutaneous melanoma: hints from occupational risks by anatomic site in Swedish men.

Authors:  B Perez-Gomez; M Pollán; P Gustavsson; N Plato; N Aragonés; G López-Abente
Journal:  Occup Environ Med       Date:  2004-02       Impact factor: 4.402

9.  Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanoma.

Authors:  Zhen Zhen Zhao; David L Duffy; Shane A Thomas; Nicholas G Martin; Nicholas K Hayward; Grant W Montgomery
Journal:  Melanoma Res       Date:  2009-04       Impact factor: 3.599

10.  Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011).

Authors:  Julie S Najita; Susan M Swetter; Alan C Geller; Jeffrey E Gershenwald; Marvin Zelen; Sandra J Lee
Journal:  J Invest Dermatol       Date:  2016-05-29       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.